Calcium Channel Blockers of Dihydropyridine Class Reduce The Antiplatelet Effect of Clopidogrel? What Is Clinical Impact

被引：2
|
作者：
Park, Sang Ho [1 ]
Rha, Seung-Woon [2 ]
Shin, Won-Yong [1 ]
Lee, Seung-Jin [1 ]
Jin, Dong-Kyu [1 ]
Lee, Se-Whan [1 ]
Park, Ji Young [2 ]
Choi, Byoung Geol [2 ]
Poddar, Kanhaiya L. [2 ]
Kumari, Meera [2 ]
Kim, Yun Kyung [2 ]
Na, Jin Oh [2 ]
Choi, Cheol Ung [2 ]
Lim, Hong Euy [2 ]
Kim, Jin Won [2 ]
Kim, Eung Ju [2 ]
Park, Chang Gyu [2 ]
Seo, Hong Seog [2 ]
Oh, Dong Joo [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Cheonan, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2011年 / 107卷 / 8A期
关键词：
D O I：
10.1016/j.amjcard.2011.02.109
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：47A / 47A
页数：1
相关论文
共 50 条
  • [31] Effect of Calcium Channel Blockers on Antiplatelet Activity of Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: Insights from the PTRG-DES Consortium
    Ahn, Houngbeom
    Chu, Hyun-Wook
    Her, Ae-Young
    Jeong, Young-Hoon
    Kim, Byeong-Keuk
    Joo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Ahn, Sung Gyun
    Lee, Sang Yeup
    Cho, Jung Rae
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Lim, Do-Sun
    Shin, Eun-Seok
    Suh, Jung-Won
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [32] Clopidogrel and calcium-channel blockers: a clinically important interaction?
    Chapman, Neil
    Schachter, Michael
    HEART, 2010, 96 (03) : 179 - 180
  • [33] CLINICALLY SIGNIFICANT ANTIPLATELET EFFECTS OF CALCIUM-CHANNEL BLOCKERS
    RING, ME
    MARTIN, GV
    FENSTER, PE
    JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (08): : 719 - 720
  • [34] An 11-year retrospective comparison of dihydropyridine and non-dihydropyridine calcium channel blockers
    Jang, David H.
    Spyres, Meghan B.
    Nelson, Lewis S.
    Hoffman, Robert S.
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 640 - 640
  • [35] THE INTERACTION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS WITH CALMODULIN AND CALMODULIN INHIBITORS
    THAYER, SA
    FAIRHURST, AS
    MOLECULAR PHARMACOLOGY, 1983, 24 (01) : 6 - 9
  • [36] Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
    Mendez, Sean R.
    Frank, Rachel C.
    Stevenson, Elizabeth K.
    Chung, Mabel
    Silverman, Michael G.
    CHEST, 2021, 160 (01) : 89 - 93
  • [37] Separation of five dihydropyridine calcium channel blockers by micellar electrokinetic chromatography
    Wang, J
    Chen, HF
    Zhao, LF
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 1999, 27 (01) : 82 - 84
  • [38] Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
    Staessen, JA
    Birkenhäger, WH
    Fagard, RH
    EUROPEAN HEART JOURNAL, 2000, 21 (01) : 2 - 7
  • [39] Time course for blood pressure lowering of dihydropyridine calcium channel blockers
    Ghamami, Niousha
    Chiang, Sandy Hsiang Yu
    Dormuth, Colin
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [40] Calcium channel blockers in combination: What we are learning from clinical trials
    Kaplan, NM
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 268A - 268A
12345